Roslin Cell Therapies is a leading UK Cell Therapy Contract Development and Manufacturing Organisation (CDMO) focused on providing services for companies developing cell based therapeutic products for both European and US clinical trials. Based at the Edinburgh BioQuarter Roslin Cell Therapies operates a fully licensed GMP manufacturing facility and has a proven track record in the delivery of cell based products for clinical trials. A comprehensive range of CDMO services is offered, ranging from: • Gap analysis • Tissue procurement • Process optimisation and scale-up • GMP manufacture • Cell banking • In - process and final product QC testing • QP batch certification • GMP storage • Controlled temperature distribution to clinical sites worldwide. As an organisation we leverage our cell therapy - focused expertise and strong links established across the UK’s regenerative medicine supply chain to de-risk client product development and support our clients in fulfilling their objective of providing compliant, sustainable and affordable therapies. With a highly experienced and professional team, we are committed to developing longstanding relationships with our clients and supporting them across all stages of Cell Therapy development while applying the highest standards of quality and service across all aspects of our business.
